Published in J Immunol on December 15, 1999
Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med (2006) 2.21
Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med (2000) 1.38
Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation. Proc Natl Acad Sci U S A (2009) 1.20
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity (2012) 1.09
Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice. J Biol Chem (2009) 1.08
Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med (2013) 1.08
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Res (2010) 1.04
Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. Mol Cell Biol (2001) 1.03
Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. J Clin Invest (2002) 0.99
Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci U S A (2001) 0.96
Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol (2008) 0.93
Leukotrienes modulate cytokine release from dendritic cells. Immunology (2005) 0.92
The 5-lipoxygenase pathway is required for acute lung injury following hemorrhagic shock. Shock (2012) 0.86
Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways. J Immunol (2013) 0.85
Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis. Inflammation (2011) 0.84
Resolution of inflammation as a novel chemopreventive strategy. Semin Immunopathol (2013) 0.84
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br J Pharmacol (2011) 0.83
Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol (2010) 0.83
Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis. J Immunol (2010) 0.82
Claude H. Organ, Jr. memorial lecture: splanchnic hypoperfusion provokes acute lung injury via a 5-lipoxygenase-dependent mechanism. Am J Surg (2010) 0.82
Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol (2014) 0.82
Bacterial challenge stimulates formation of arachidonic acid metabolites by human keratinocytes and neutrophils in vitro. Clin Diagn Lab Immunol (2002) 0.81
Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia. Biochim Biophys Acta (2014) 0.78
Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema. Bioorg Med Chem Lett (2011) 0.78
Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection. Nat Commun (2015) 0.78
The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals. Clin Exp Immunol (2001) 0.77
Niacin inhibits carrageenan-induced neutrophil migration in mice. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.75
Brca1 controls homology-directed DNA repair. Mol Cell (1999) 7.82
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem (2001) 5.74
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science (1994) 3.97
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (1992) 3.50
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet (1996) 2.99
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest (2001) 2.86
A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 2.77
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature (1997) 2.56
Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell (1993) 2.54
Retracted BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science (1998) 2.48
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem (2000) 2.44
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol (1985) 2.43
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science (1992) 2.36
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A (1987) 2.31
A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol (1999) 2.26
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 2.25
Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity (1999) 2.14
Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. Proc Natl Acad Sci U S A (1984) 1.93
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest (1999) 1.66
Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A (1994) 1.59
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.53
Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med (1997) 1.53
Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice. J Biol Chem (1999) 1.51
Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol (1999) 1.50
Hexachlorophane for treating carriers of Staphylococcus aureus. Lancet (1970) 1.49
Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest (1998) 1.46
Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest (2000) 1.40
Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(-) transport. J Biol Chem (1999) 1.39
Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity (1998) 1.36
Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med (1990) 1.33
Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol (1999) 1.33
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest (2001) 1.29
Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice. J Exp Med (1997) 1.29
Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ (1999) 1.28
A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation. Exp Cell Res (1995) 1.26
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest (1996) 1.25
The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments. J Immunol (1992) 1.25
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation (2000) 1.21
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model. J Med Chem (1994) 1.19
Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med (1997) 1.19
Anaphylaxis mediated through a humanized high affinity IgE receptor. J Immunol (1996) 1.18
Failure of spermatogenesis in mouse lines deficient in the Na(+)-K(+)-2Cl(-) cotransporter. J Clin Invest (2000) 1.17
Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am J Physiol (1998) 1.16
Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J Immunol (1999) 1.10
The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol (1998) 1.09
Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J Exp Med (1996) 1.07
Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Cancer Res (2001) 1.06
Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation (1992) 1.01
A murine model of cystic fibrosis. Am J Respir Crit Care Med (1995) 1.00
BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem (2001) 1.00
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung. Br J Pharmacol (1986) 0.99
Organization of the human class I major histocompatibility complex genes. Immunol Res (1987) 0.99
Pulmonary tuberculosis due to Mycobacterium bovis. Thorax (1986) 0.96
Intestinal ion transport in NKCC1-deficient mice. Am J Physiol Gastrointest Liver Physiol (2000) 0.94
HLA-AR, an inactivated antigen-presenting locus related to HLA-A. Implications for the evolution of the MHC. J Immunol (1990) 0.94
Liquid and ion transport by fetal airway and lung epithelia of mice deficient in sodium-potassium-2-chloride transporter. Am J Respir Cell Mol Biol (2001) 0.93
GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF. Cytokine (1995) 0.93
Examination of four HLA class I pseudogenes. Common events in the evolution of HLA genes and pseudogenes. J Immunol (1992) 0.93
Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm Res (1995) 0.92
Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics. Am J Physiol Heart Circ Physiol (2001) 0.89
HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility. J Urban Health (2000) 0.89
Alterations in airway ion transport in NKCC1-deficient mice. Am J Physiol Cell Physiol (2001) 0.88
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy. J Pharmacol Exp Ther (1997) 0.87
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proc Natl Acad Sci U S A (1988) 0.87
The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. J Pharmacol Exp Ther (1998) 0.87
Haemoglobin A1c levels in normal and diabetic pregnancies. Eur J Obstet Gynecol Reprod Biol (1987) 0.87
Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J Immunol (1999) 0.86
Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene. J Immunol (1988) 0.86
Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice. Toxicol Sci (2001) 0.86
CD8+ T lymphocytes are not required for murine resistance to human filarial parasites. J Parasitol (1992) 0.86
Effect of 6 keto-prostaglandin E on sympathetic neurotransmission in the vas deferens. J Pharm Pharmacol (1983) 0.85
Pre-synaptic and post-synaptic effects of xylazine and naphazoline on the bisected rat vas deferens. Arch Int Pharmacodyn Ther (1982) 0.85
Ultrastructure of the inner ear of NKCC1-deficient mice. Hear Res (2001) 0.85
Comparison of multiple HLA-A alleles at the DNA level by using Southern blotting and HLA-A-specific probes. J Immunol (1985) 0.84
A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Br J Pharmacol (1988) 0.84
Phenotypic analysis of mice lacking the highly abundant Purkinje cell- and bipolar neuron-specific PCP2 protein. Mol Cell Neurosci (1997) 0.83
The effect of sepsis rates of closing and cleaning hospital wards. J Clin Pathol (1971) 0.83
Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice. Transplantation (1993) 0.83
Bovine variants of Mycobacterium tuberculosis isolated in Liverpool during the period 1969 to 1983: an epidemiological survey. Q J Med (1986) 0.83
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram. Br J Pharmacol (1996) 0.82
Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. J Neural Transm (Vienna) (2007) 0.82